Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cε

Journal of Clinical Investigation

Volumn 110, Issue 7, 2002, Pages 1003-1010

  Hodge, Clyde W ^a   Raber, Jacob ^a   McMahon, Thomas ^a   Walter, Helen ^a   Sanchez Perez, Ana Maria ^a   Foster Olive, M ^a   Mehmert, Kristin ^a   Leslie Morrow, A ^b   Messing, Robert O ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ALFAXALONE; ANXIOLYTIC AGENT; BICUCULLINE; CORTICOSTERONE; CORTICOTROPIN; ELTANOLONE; HORMONE; NEUROSTEROID; PROTEIN KINASE C; STRESS HORMONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME ANALYSIS; HORMONE DETERMINATION; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; CORTICOSTERONE; ISOENZYMES; MICE; MICE, INBRED C57BL; PREGNANOLONE; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; RECEPTORS, GABA-A;

EID: 0036792496     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200215903     Document Type: Article

References (35)

1. Kessler, RC., et al. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 51:8-19.
2. Deckert, J., et al. 1999. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Mol. Genet. 8:621-624.
3. Deckert, J., et al. 1998. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol. Psychiatry. 3:81-85.
4. Kennedy, J.L., et al. 1999. Investigation of cholecystokinin system genes in panic disorder. Mol. Psychiatry 4:284-285.
5. Wang, Z., Valdes, J., Noyes, R., Zoega, T., and Crowe, R.R. 1998. Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder. Am. J Med. Genet. 81:228-234.
6. Turri, M.G., Datta, S.R, DeFries, J., Henderson, N.D., and Flint, J. 2001. QTL analysis identifies multiple behavioral dimensions in ethological tests ofanxiety in laboratory mice. Curr. Biol. 11:725-734.
7. Smith, G.W., et al. 1998 Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 20:1093-1102.
8. Timpl, P., et al. 1998. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19:162-166.
9. Tronche, F, et al. 1999. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23:99-103.
10. Chen, C., Rainnie, D.G., Greene, R.W., and Tonegawa, S. 1994. Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II. Science. 266:291-294.
11. Bowers, BJ., Collins, A.C., Tritto,T., and Wehner, J.M. 2000. Mice lacking PKC gamma exhibit decreased anxiety. Behav. Genet. 30:111-121.
12. Kash, S.F., Tecott, L.H., Hodge, C., and Baekkeskov, S. 1999. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA. 96:1698-1703.
13. Crestani, F., et al. 1999. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat. Neurosci. 2:833-839.
14. Bale, T.L., et al. 2000. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 24:410-414.
15. Kishimoto, T., et al 2000. Deletion ofcrhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet 24:415-419.
16. Heisler, L.K, et al. 1998. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad. Sci. USA. 95:15049-15054.
17. Parks, C.L., Robinson, P.S., Sibille, E., Shenk, T., and Toth, M. 1998. Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. USA. 95:10734-10739.
18. Ramboz, S., et al. 1998. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc. Natl. Acad. Sci. USA. 95:14476-14481.
19. Salzman, C., Miyawaki, E.K., le Bars, P., and Kerrihard, T.N. 1993. Neurobiologic basis of anxiety and its treatment. Harv. Rev. Psychiatry. 1:197-206.
20. A receptor modulators and alcohol in mice lacking PKCε. Nat. Neurosci. 2:997-1002.
21. Khasar, S.G., et al. 1999. A novel nociceptor signaling pathway revealed in protein kinase C ε mutant mice. Neuron. 24:253-260
22. Olive, M.F., Mehmert, K.K., Messing, R.O., and Hodge, C.W. 2000. Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCε-deficient mice. Eur. J. Neurosci. 12:4131-4140.
23. VanDoren, M.J., et al. 2000. Neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J. Neurosci. 20:1982-1989.
24. Kiley, S.C., and Parker, P.J. 1995. Differential localization of protein kinase C isozymes in U937 cells: evidence for distinct isozyme functions during monocyte differentiation. J. Cell Sci. 108:1003-1016.
25. Crawley, J.N. 2000. What's wrong with my mouse? Wiley-Liss. New York, New York, USA. 329 pp.
26. Paul, S.M., and Purdy, R.H. 1992. Neuroactive steroids. FASEB J. 6:2311-2322.
27. Herman,J.P., and Cullinan, W.E. 1997. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20:78-84.
28. Dalvi, A., and Rodgers, R.J. 1996. GABAergic influences on plus-maze behaviour in mice. Psychopharmacology (Berl). 128:380-397.
29. Yajima, Y., et al. 2000. Effects of differential modulation of mu-, delta-and kappa-opioid systems on bicuculline-induced convulsions in the mouse. Brain Res. 862:120-126.
30. Patchev, V.K., Shoaib, M., Holsboer, F., and Almeida, O.F.X. 1994. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience. 62:265-271
31. Hundle, B., et al. 1997. An inhibitory fragment derived from protein kinase Cε prevents enhancement of nerve growth factor responses by ethanol and phorbol esters. J. Biol. Chem. 272:15028-15035.
32. Kellenberger, S., Malherbe, P., and Sigel, E. 1992. Function of the αlβ2γ2S γ-aminobutyric acid type A receptor is modulated by protein kinase C via multiple phosphorylation sites. J. Biol. Chem. 267:25660-25663.
33. A receptor function by protein kinase C phosphorylation. Neuron. 12:1081-1095.
34. Lin, Y.F., et al. 1996. Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acid A receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits. Mol. Pharmacol. 50:185-195.
35. Harris, R.A., McQuilkin, SJ., Paylor, R., Tonegawa, S., and Wehner, J.M., 1995. Mutant mice lacking the γ isoform of protein kinase C show decreased behavioral actions of ethanol and altered function of γ-aminobutyrate type A receptors. Proc. Natl. Acad. Sci. USA. 92:3658-3662.